FinalSpark SA is a Swiss biocomputing startup operating the first remotely accessible research platform using living human brain organoids as computational substrates. Founded in 2014 by Dr. Fred Jordan and Dr. Martin Kutter in Vevey, Switzerland, the company developed its Neuroplatform after pivoting from conventional AI algorithms to biological computing in 2018.

The Neuroplatform comprises brain organoids (three-dimensional clusters of approximately 10,000 neurons each, derived from human induced pluripotent stem cells) cultured on multi-electrode arrays (MEAs). Researchers interact with the organoids via electrical stimulation and record neural responses, accessing the system remotely through a browser interface or Python API. The company has scaled to over 1,000 organoids and collected more than 18 terabytes of experimental data. Current organoid lifespan averages approximately 100 days.

FinalSpark targets academic researchers and commercial clients interested in wetware computing, offering monthly subscription access to its laboratory. Ten universities worldwide participate in an open research initiative, including institutions in the UK, Germany, France, and the US. The company's long-term thesis is that biological neural networks can eventually complement silicon for AI workloads at dramatically lower energy consumption. FinalSpark holds three patents and has published in Frontiers in Artificial Intelligence.